Literature DB >> 27602134

Influence of autologous dendritic cells on cytokine-induced killer cell proliferation, cell phenotype and antitumor activity in vitro.

Jingsong Cao1, Cong Chen2, Yuhuan Wang1, Xuecheng Chen3, Zeying Chen4, Xiaoling Luo1.   

Abstract

Dendritic cell (DCs) are essential antigen processing and presentation cells that play a key role in the immune response. In this study, DCs were co-cultured with cytokine-induced killer cells (DC-CIKs) in vitro to detect changes in cell proliferation, cell phenotype and cell cytotoxicity. The results revealed that the DCs were suitable for co-culture with CIKs at day 7, and that cell quantity of DC-CIKs was lower than that of CIKs until day 11, but it was significantly improved to 1.17-fold that of CIKs at day 13. Flow cytometry was used to detect the cell phenotype of CIKs and DC-CIKs. Compared with CIKs at day 13, the percentage of CD3+, CD3+CD4+, CD3+CD8+ and CD3+CD56+ T cells in DC-CIKs was significantly improved 1.02, 1.79, 1.26 and 2.44-fold, respectively. In addition, trypan blue staining analysis demonstrated that the cell viability of CIKs and DC-CIKs was 96% and 98%, respectively. Furthermore, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis verified that CIK and DC-CIK cytotoxicity in Hela cells was 58% and 80%, respectively, with a significant difference. Taken together, our results indicate that the cell proliferation, cell phenotype and antitumor activity of CIKs were all enhanced following co-culture with DCs in vitro. These results are likely to be useful for DC-CIK application in antitumor therapies.

Entities:  

Keywords:  MTT; cytokine-induced killer cells; dendritic cells; flow cytometry

Year:  2016        PMID: 27602134      PMCID: PMC4998518          DOI: 10.3892/ol.2016.4839

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers.

Authors:  Yajing Zhang; Lei Xia; Yan Zhang; Yao Wang; Xuechun Lu; Fengxia Shi; Yang Liu; Meixia Chen; Kaixhao Feng; Wenying Zhang; Xiaobing Fu; Weidong Han
Journal:  Expert Opin Biol Ther       Date:  2014-12-01       Impact factor: 4.388

2.  A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role.

Authors:  Weng-Chee Chan; Yeh-Ching Linn
Journal:  Cytotechnology       Date:  2014-12-07       Impact factor: 2.058

Review 3.  Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.

Authors:  Y C Linn; Kam M Hui
Journal:  Leuk Lymphoma       Date:  2003-09

4.  T-Bet Mediated Anti-Neoplastic Effects of Dendritic Cell-Cytokine Induced Killer Cells in vitro.

Authors:  Liu Miao; Jin Run-Ming; Jiang Yi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

5.  Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Authors:  Bruno Salaun; Takuya Yamamoto; Bassam Badran; Yasuko Tsunetsugu-Yokota; Antoine Roux; Lukas Baitsch; Redouane Rouas; Hussein Fayyad-Kazan; Petra Baumgaertner; Estelle Devevre; Anirudh Ramesh; Marion Braun; Daniel Speiser; Brigitte Autran; Philippe Martiat; Victor Appay; Pedro Romero
Journal:  J Transl Med       Date:  2011-04-20       Impact factor: 5.531

6.  Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer.

Authors:  Mayu O Frank; Julia Kaufman; Salina Parveen; Nathalie E Blachère; Dana E Orange; Robert B Darnell
Journal:  J Transl Med       Date:  2014-12-05       Impact factor: 5.531

7.  Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapy.

Authors:  Hui Zhu; Xuejing Yang; Jiali Li; Yanjie Ren; Tianyu Zhang; Chunze Zhang; Jintai Zhang; Jing Li; Yan Pang
Journal:  Biomed Res Int       Date:  2014-07-17       Impact factor: 3.411

8.  Dendritic cell defects in patients with cancer: mechanisms and significance.

Authors:  Corrine Lenahan; David Avigan
Journal:  Breast Cancer Res       Date:  2006-01-05       Impact factor: 6.466

9.  Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture.

Authors:  Martin Bach; Christoph Schimmelpfennig; Alexandra Stolzing
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

10.  Sunitinib indirectly enhanced anti-tumor cytotoxicity of cytokine-induced killer cells and CD3⁺CD56⁺ subset through the co-culturing dendritic cells.

Authors:  Adisak Wongkajornsilp; Valla Wamanuttajinda; Kanda Kasetsinsombat; Sunisa Duangsa-ard; Khanit Sa-ngiamsuntorn; Suradej Hongeng; Kittipong Maneechotesuwan
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more
  7 in total

1.  The effects of hemocyanin on T cells cultured in vitro.

Authors:  Jiani Liu; Cong Chen; Chen Ling; Haoyun Hu; Jingsong Cao; Yongqiang Gao
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

2.  HLA-E inhibitor enhances the killing of neuroblastoma stem cells by co-cultured dendritic cells and cytokine-induced killer cells loaded with membrane-based microparticles.

Authors:  Zijun Zhen; Kaibin Yang; Litong Ye; Zhiyao You; Rirong Chen; Ying Liu; Youjian He
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

3.  Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer.

Authors:  Chunyan Liu; Yingying Zheng; Junyi Tang; Dawei Wang; Zhenshen Ma; Shutong Li; Xiaotian Chang
Journal:  J Immunol Res       Date:  2019-03-03       Impact factor: 4.818

4.  Oral S2-Ag85 DNA Vaccine Activated Intestinal Cell dsDNA and RNA Sensors to Promote the Presentation of Intestinal Antigen.

Authors:  Dang Sheng; Sui Xin; Wu Dongxing; Wen Shubo; Song Yang; Chen Zeliang; Zhai Jingbo
Journal:  J Immunol Res       Date:  2022-04-13       Impact factor: 4.493

5.  The influence of HK2 blood group antigen on human B cell activation for ABOi-KT conditions.

Authors:  Jingsong Cao; Luogen Liu; Yunsheng Zhang; Jianhua Xiao; Yi Wang
Journal:  BMC Immunol       Date:  2017-12-16       Impact factor: 3.615

Review 6.  Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.

Authors:  Xingchun Gao; Yajing Mi; Na Guo; Hao Xu; Lixian Xu; Xingchun Gou; Weilin Jin
Journal:  Front Immunol       Date:  2017-07-06       Impact factor: 7.561

Review 7.  Efficacy and Safety of Immunotherapy for Cervical Cancer-A Systematic Review of Clinical Trials.

Authors:  Mona W Schmidt; Marco J Battista; Marcus Schmidt; Monique Garcia; Timo Siepmann; Annette Hasenburg; Katharina Anic
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.